Security key
40637H109
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 115,142,534
- Total 13F value
- $1,492,238,870
- Share change
- +14,839,689
- Put/Call ratio
- 31%
- SEC-reported price per share
- $12.96
- Number of holders
- 155
- Value change
- +$198,524,663
- Number of buys
- 60
- Number of sells
- 85
- Shares outstanding
- 118,494,184
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
155
Top holders
10
HALO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
HALOZYME THERAPEUTICS, INC. SEC filings
HALOZYME THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 40637H109
Recent filing periods:
Ownership snapshot
Top reported holders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Third Security, LLC
Disclosed value leader
Third Security, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 16%
Showing 1-6 of 15 holder rows.
Quick read
Third Security, LLC leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Third Security, LLC's linked filing trail.
Comparable ownership
Top 5
Third Security, LLC
16%
IRIDIAN ASSET MANAGEMENT LLC/CT
9.1%
VANGUARD GROUP INC
7.1%
First Eagle Investment Management...
6.5%
BB BIOTECH AG
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Security, LLC |
13F
Company
|
16%
|
$190,737,000
19,305,403 shares
|
— | 31 Dec 2016 |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
Company
|
9.1%
|
$106,105,000
10,739,413 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
7.1%
|
$83,509,000
8,452,343 shares
|
— | 31 Dec 2016 |
| First Eagle Investment Management, LLC |
13F
Company
|
6.5%
|
$75,953,000
7,687,515 shares
|
— | 31 Dec 2016 |
| BB BIOTECH AG |
13F
Company
|
6.4%
|
$75,086,000
7,599,832 shares
|
— | 31 Dec 2016 |
| FMR LLC |
13F
Company
|
5.7%
|
$66,852,000
6,766,382 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
155
Shares
115,142,534
Rows available
155
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q1 2017 Across Filers
Q1 2017 holders
155
Q1 2017 holders
155
Holder diff
0
| Investor | Q1 2017 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend